Transfemoral versus transcarotid access for transcatheter aortic valve replacementCentral MessagePerspective

Transfemoral versus transcarotid access for transcatheter aortic valve replacementCentral MessagePerspective

Objectives: To compare the outcomes after transcatheter aortic valve replacement (TAVR) through a transfemoral (TF) and transcarotid (TC) access at our institution. Methods: From January 2014 to January 2020, 62 TC-TAVR and 449 TF-TAVR were performed using 2 prosthesis devices (Edwards SAPIEN 3, n =...

Full description

Saved in:
Bibliographic Details
Main Authors: Maud-Emmanuelle Olivier, MD, Alessandro Di Cesare, MD, Anne Poncet, MD, Camille Brasselet, MD, PhD, Damien Metz, MD, PhD, Fausto Biancari, MD, PhD, Vito Giovanni Ruggieri, MD, PhD, Laurent Faroux, MD, Salvatore Muccio, MD, Pierre-Frédéric Torossian, MD, Sébastien Duval, MD, Li Liu, MD, Emmanuelle Durand, MD, Sophie Tassan, MD, Virginie Heroguelle, MD
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:JTCVS Techniques
Subjects:
transcatheter aortic valve replacement
TAVR
TAVI
aortic stenosis
carotid artery
Online Access:http://www.sciencedirect.com/science/article/pii/S2666250722003728
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives: To compare the outcomes after transcatheter aortic valve replacement (TAVR) through a transfemoral (TF) and transcarotid (TC) access at our institution. Methods: From January 2014 to January 2020, 62 TC-TAVR and 449 TF-TAVR were performed using 2 prosthesis devices (Edwards SAPIEN 3, n = 369; Medtronic Evolut R, n = 142). Propensity score matching was used to adjust for imbalance in the baseline characteristics of the study groups. Results: Propensity score matching provided 62 matched pairs with comparable operative risk (mean European System for Cardiac Operative Risk Evaluation II, TC-TAVR 7.6% vs TF-TAVR 6.6%, P = .17). Thirty-day mortality (4.8% vs 3.2%, P = 1.00) and 2-year mortality (11.3% vs 12.9%, P = .64) after TC-TAVR were comparable with TF-TAVR. Strokes were numerically more frequent after TC-TAVR compared with TF-TAVR (3.2% vs 0%, P = .23), but the difference did not reach statistical significance. TF-TAVR was associated with a significantly greater risk of permanent pacemaker implantation (29.0% vs 12.9%, P = .04) compared with TC-TAVR. Other complications were not frequent and were similarly distributed between the matched groups. Conclusions: TC access for TAVR was associated with satisfactory results compared to the femoral access. TC-TAVR could be considered a valid and safe alternative to TF-TAVR when femoral access is contraindicated.
ISSN:2666-2507

Similar Items